Showing 2471-2480 of 4166 results for "".
- Digital Vision and Neurolens Collaborate to Increase Prism Specificityhttps://modernod.com/news/digital-vision-and-neurolens-collaborate-to-increase-prism-specificity/2480297/With the aim of providing a new standard of care when addressing the growing prevalence of eye misalignment, Neurolens and Digital
- EyeQue Offers Free At-Home Vision Testshttps://modernod.com/news/eyeque-offers-free-at-home-vision-tests/2477594/EyeQue is giving away free
- Chiropractic Treatment and Vision Loss: Examining the Connectionhttps://modernod.com/news/chiropractic-treatment-and-vision-loss-examining-the-connection/2479828/Many Americans visit chiropractors to address pain, often without informing their physicians. And they might not consider eye complications that could result, says Yannis Paulus, MD, a retina specialist at the University of Michigan Kellogg Eye Center. The energetic thrusts and rota
- Ocular Therapeutix to Present Preclinical and Clinical Data at ARVOhttps://modernod.com/news/ocular-therapeutix-to-present-preclinical-and-clinical-data-at-arvo/2479146/Ocular Therapeutix announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting. With the ARVO 2021 Annual Meeting being moved to a virtual format, video-recorded presentations are scheduled to become available online at ARVOLearn o
- Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseaseshttps://modernod.com/news/ocumension-therapeutics-strengthens-pipeline-for-posterior-segment-eye-diseases/2478482/Ocumension Therapeutics announced that the company has entered into a collaboration and exclusive promotion agreement with Shandong Boan Biological Technology, a wholly-owned subsidiary of Luye Pharma Group, to jointly develop OT-702 (LY09004), a biosimilar to Eylea (aflibercept). Ocumension has
- CooperVision Acquires Blanchard Contact Lenses, Expanding Presence in Specialty Segmenthttps://modernod.com/news/coopervision-acquires-blanchard-contact-lenses-expanding-presence-in-specialty-segment/2476206/CooperVision has acquired Blanchard Contact Lenses, a maker of scleral lenses. Terms of the deal were not disclosed. Blanchard, with its network of distributors, operates in North America, Europe (including Scandinavia), Central America, and South America. Its recently introduced On
- China’s NMPA Approves Zeiss Artevo 750 and Artevo 850 Ophthalmic Microscopeshttps://modernod.com/news/chinas-nmpa-approves-zeiss-artevo-750-and-artevo-850-ophthalmic-microscopes/2485563/Zeiss announced that China’s National Medical Products Administration (NMPA) has approved the Zeiss Artevo 750 and Zeiss Artevo 850 ophthalmic microscopes. Designed to support both anterior and posterior segment procedures, th
- Optikon Introduces R-Evo Smart for Cataract and Retinal Surgeryhttps://modernod.com/news/optikon-introduces-r-evo-smart-for-cataract-and-retinal-surgery/2479806/Optikon has introduced R-Evo smart, a compact platform that allows anterior and posterior segment surgeries to be performed with the same cassette. The R-Evo equipment is available in disposable and reusable versions.
- Johnson & Johnson Vision Reveals New Data on Blue-Violet Light Filtering Technology in Acuvue Oasys Max 1-Day Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-reveals-new-data-on-blue-violet-light-filtering-technology-in-acuvue-oasys-max-1-day-contact-lenses/2481196/Johnson & Johnson Vision Care will present new data on the positive effects of wearing blue-violet light filtering contact lenses at the 2022 American Academy of Optometry (AAO) annual meeting in San Diego, October 26-29. "As a result of our increasingly digital
- B+L Enrolls First Patient in LASIK Trial Evaluating Technolas Teneo Excimer Laser for Vision Correction Surgery for Hyperopia with Astigmatismhttps://modernod.com/news/bausch-lomb-enrolls-first-patient-in-lasik-clinical-trial-evaluating-use-of-technolas-teneo-excimer-laser-for-vision-correction-surgery-for-hyperopia-with-astigmatism/2480988/Bausch + Lomb announced that the company has enrolled the first patient in a study evaluating the safety and efficacy of the Technolas Teneo excimer laser for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for hyperopia with astigmatism. &quo